Survival Rate by Time Point

A count of surviving mice was tallied at each predetermined study interval. The survivor counts are plotted for each drug and placebo. Overall, a downward trend is expected given the malignancy of the disease. When comparing trends, however, only three mice died in the Capomulin arm while all others lost approximately 3/4 their respective population. Capomulin shows a clear advantage in survival rate.